SwePub
Sök i LIBRIS databas

  Extended search

onr:"20821238"
 

Search: onr:"20821238" > Serglycin as a pote...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Serglycin as a potential biomarker for glioma association of serglycin expression, extent of mast cell recruitment and glioblastoma progression

Roy, Ananya (author)
Attarha, Sanaz (author)
Weishaupt, Holger (author)
show more...
Edqvist, Per-Henrik (author)
Swartling, Fredrik J. 1975- (author)
Bergqvist, Michael (author)
Siebzehnrubl, Florian A. (author)
Smits, Anja (author)
Pontén, Fredrik (author)
Tchougounova, Elena (author)
show less...
 (publisher)
 (publisher)
show more...
 (publisher)
 (publisher)
show less...
2017
2017
English.
In: OncoTarget. - 1949-2553. ; 8:15, 24815-24827
  • swepub:Mat__t
Abstract Subject headings
Close  
  • Serglycin is an intracellular proteoglycan with a unique ability to adopt highly divergent structures by glycosylation with variable types of glycosaminoglycans (GAGs) when expressed by different cell types. Serglycin is overexpressed in aggressive cancers suggesting its protumorigenic role. In this study, we explored the expression of serglycin in human glioma and its correlation with survival and immune cell infiltration. We demonstrate that serglycin is expressed in glioma and that increased expression predicts poor survival of patients. Analysis of serglycin expression in a large cohort of low- and high-grade human glioma samples reveals that its expression is grade dependent and is positively correlated with mast cell (MC) infiltration. Moreover, serglycin expression in patient-derived glioma cells is significantly increased upon MC co-culture. This is also accompanied by increased expression of CXCL12, CXCL10, as well as markers of cancer progression, including CD44, ZEB1 and vimentin.In conclusion, these findings indicate the importance of infiltrating MCs in glioma by modulating signaling cascades involving serglycin, CD44 and ZEB1. The present investigation reveals serglycin as a potential prognostic marker for glioma and demonstrates an association with the extent of MC recruitment and glioma progression, uncovering potential future therapeutic opportunities for patients.

Subject headings

Medical and Health Sciences  (hsv)
Clinical Medicine  (hsv)
Cancer and Oncology  (hsv)
Medicin och hälsovetenskap  (hsv)
Klinisk medicin  (hsv)
Cancer och onkologi  (hsv)

Keyword

CD44
ZEB1
glioma
mast cell
serglycin

Find in a library

  • OncoTarget (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view